J. Binder Et Al. , "Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?," ULTRASOUND IN OBSTETRICS & GYNECOLOGY , vol.59, no.2, pp.192-201, 2022
Binder, J. Et Al. 2022. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?. ULTRASOUND IN OBSTETRICS & GYNECOLOGY , vol.59, no.2 , 192-201.
Binder, J., KALAFAT, E., Palmrich, P., Pateisky, P., & Khalil, A., (2022). Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?. ULTRASOUND IN OBSTETRICS & GYNECOLOGY , vol.59, no.2, 192-201.
Binder, J. Et Al. "Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?," ULTRASOUND IN OBSTETRICS & GYNECOLOGY , vol.59, no.2, 192-201, 2022
Binder, J. Et Al. "Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?." ULTRASOUND IN OBSTETRICS & GYNECOLOGY , vol.59, no.2, pp.192-201, 2022
Binder, J. Et Al. (2022) . "Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?." ULTRASOUND IN OBSTETRICS & GYNECOLOGY , vol.59, no.2, pp.192-201.
@article{article, author={J. Binder Et Al. }, title={Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?}, journal={ULTRASOUND IN OBSTETRICS & GYNECOLOGY}, year=2022, pages={192-201} }